Income statement
USD
Annual
| Metric | 2019 | 2018 | 2017 | 2016 | 1999 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 4M |
| Gross Profit | 0 | 0 | 0 | 0 | 2M |
| Operating Income | -5K | -2K | -3K | -6K | -92K |
| EBITDA | -5K | -2K | -3K | -6K | 763K |
| Net Income | -5K | -2K | -3K | -6K | -14K |
| EPS (Diluted) | — | — | — | — | — |
Utilities
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 253 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ViviCells International, Inc. (VCII) is a Utilities stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +100.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +100.0%, free cash flow 0.0% with operating margin 0.0% and ROIC -0.7%. Stock Foundry combines VCII price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Utilities peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VCII
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VCII Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VCII and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$4.2M
FY Net Income
-$14.4K
-123.8% YoY
Free Cash Flow
-$1.3M
Revenue Growth
+0.0%
EPS Growth
+100.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2019 | 2018 | 2017 | 2016 | 1999 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 4M |
| Gross Profit | 0 | 0 | 0 | 0 | 2M |
| Operating Income | -5K | -2K | -3K | -6K | -92K |
| EBITDA | -5K | -2K | -3K | -6K | 763K |
| Net Income | -5K | -2K | -3K | -6K | -14K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2019 | 2018 | 2017 | 2016 | 1999 |
|---|---|---|---|---|---|
| Cash & Equivalents | 0 | 0 | 4K | 43K | 30K |
| Total Assets | 813K | 813K | 817K | 855K | 5M |
| Total Liabilities | 104K | 96K | 102K | 113K | 3M |
| Shareholder Equity | 709K | 716K | 715K | 742K | 2M |
| Total Debt | 72K | 68K | 68K | 68K | 3M |
| Net Debt | 72K | 68K | 64K | 25K | 3M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1M
Capital Expenditures
49K
Free Cash Flow
1M
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-0.7%
Debt / Equity
0.10x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.